Mankind Pharma Ltd. | Large-cap | Healthcare
₹2,333.40
1.30%
| Mankind Pharma Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 122.1B
Gross Profit 87.2B 71.42%
Operating Income 24.0B 19.63%
Net Income 20.1B 16.47%
EPS (Diluted) ₹49.20

Balance Sheet Metrics

Total Assets 277.6B
Total Liabilities 131.9B
Shareholders Equity 145.7B
Debt to Equity 0.91

Cash Flow Metrics

Operating Cash Flow 26.5B
Free Cash Flow 18.9B

Revenue & Profitability Trend

Mankind Pharma Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 122.1B 103.3B 87.5B 77.8B 62.1B
Cost of Goods Sold 34.9B 32.7B 29.6B 24.7B 18.2B
Gross Profit 87.2B 70.7B 57.9B 53.1B 43.9B
Operating Expenses 30.1B 20.8B 18.7B 16.2B 12.7B
Operating Income 24.0B 22.3B 16.4B 18.8B 16.1B
Pre-tax Income 25.2B 24.0B 16.7B 19.7B 16.9B
Income Tax 5.1B 4.6B 3.6B 5.2B 4.0B
Net Income 20.1B 19.4B 13.1B 14.5B 12.9B
EPS (Diluted) ₹49.20 ₹47.68 ₹32.00 ₹35.78 ₹31.59

Income Statement Trend

Mankind Pharma Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 69.9B 65.7B 43.3B 44.1B 39.1B
Non-Current Assets 207.7B 54.0B 53.9B 47.4B 24.7B
Total Assets 277.6B 119.6B 97.2B 91.5B 63.7B
Liabilities
Current Liabilities 56.6B 21.2B 18.6B 26.2B 13.5B
Non-Current Liabilities 75.3B 2.7B 2.3B 2.1B 1.6B
Total Liabilities 131.9B 23.9B 20.9B 28.3B 15.1B
Equity
Total Shareholders Equity 145.7B 95.8B 76.2B 63.2B 48.6B

Balance Sheet Composition

Mankind Pharma Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 25.2B 24.0B 16.7B 19.7B 16.9B
Operating Cash Flow 26.5B 21.7B 18.4B 9.0B 15.7B
Investing Activities
Capital Expenditures -4.5B -3.1B -7.8B -4.6B -3.0B
Investing Cash Flow -127.0B -20.5B -10.2B 4.8B -12.5B
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow 58.6B -3.1B -24.6B -211.0M -72.8M
Free Cash Flow 18.9B 17.7B 9.8B -14.3B 8.2B

Cash Flow Trend

Mankind Pharma Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 47.09
Forward P/E 37.40
Price to Book 6.64
Price to Sales 7.80
PEG Ratio 37.40

Profitability Ratios

Profit Margin 16.31%
Operating Margin 14.69%
Return on Equity 16.62%
Return on Assets 7.54%

Financial Health

Current Ratio 1.23
Debt to Equity 58.43
Beta 0.48

Per Share Data

EPS (TTM) ₹49.00
Book Value per Share ₹347.44
Revenue per Share ₹302.16

Financial data is updated regularly. All figures are in the company's reporting currency.